<?xml version="1.0"?>
<?xml-stylesheet type="text/css" href="http://www.feuxdelamour.com/v4/skins/common/feed.css?303"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="fr">
		<id>http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=Ways_To_Spot_A_Legitimate_MK-2206</id>
		<title>Ways To Spot A Legitimate MK-2206 - Historique des versions</title>
		<link rel="self" type="application/atom+xml" href="http://www.feuxdelamour.com/v4/index.php?action=history&amp;feed=atom&amp;title=Ways_To_Spot_A_Legitimate_MK-2206"/>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=Ways_To_Spot_A_Legitimate_MK-2206&amp;action=history"/>
		<updated>2026-04-11T09:52:35Z</updated>
		<subtitle>Historique pour cette page sur le wiki</subtitle>
		<generator>MediaWiki 1.20alpha</generator>

	<entry>
		<id>http://www.feuxdelamour.com/v4/index.php?title=Ways_To_Spot_A_Legitimate_MK-2206&amp;diff=55401&amp;oldid=prev</id>
		<title>Angle3oil : Page créée avec « Patients were asked to enroll and provide a written informed consent. Patients who were unable to give an informed consent (e.g. critically ill patients) were not approach... »</title>
		<link rel="alternate" type="text/html" href="http://www.feuxdelamour.com/v4/index.php?title=Ways_To_Spot_A_Legitimate_MK-2206&amp;diff=55401&amp;oldid=prev"/>
				<updated>2017-01-07T13:32:39Z</updated>
		
		<summary type="html">&lt;p&gt;Page créée avec « Patients were asked to enroll and provide a written informed consent. Patients who were unable to give an informed consent (e.g. critically ill patients) were not approach... »&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Nouvelle page&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Patients were asked to enroll and provide a written informed consent. Patients who were unable to give an informed consent (e.g. critically ill patients) were not approached. Surveillance KPC KP rectal cultures were collected as previously [http://www.selleckchem.com/products/MK-2206.html MK-2206] described [19] at five time-points: before discharge, and at 2 weeks, 1, 2 and 3 months following hospital discharge (Fig.?S1). A selected group of persistently KPC KP positive patients (positive on their 4 or 5th tests) was sampled also at a sixth time period. Data were collected at enrollment and at each time-point by a patient's enrollment form that included demographics, exposures to antibiotics, underlying conditions and invasive devices, as well as the Barthel's (ADL) index [20] and the Charlson's co-morbidities [http://en.wikipedia.org/wiki/TRIB1 TRIB1] score [21], and a follow-up form that included questions regarding recent ([http://www.selleckchem.com/products/pci-32765.html Ibrutinib cost] KP, by either surveillance or clinical cultures, to the time of hospital discharge: acquisition of KPC KP at less or more than 4?months from discharge was considered recent (REC) or remote (REM), respectively (see Fig.?1). This division was undertaken as survival analysis was deemed inappropriate for the patients with remote acquisition. Associations between REC/REM groups and other baseline demographic and clinical variables were evaluated with analysis of variance, Kruskal�CWallis or chi-squared tests. In the REC group, the association between the baseline demographic and clinical variables and time to KPC KP clearance is presented as Kaplan�CMeier curves and compared using the Log Rank test.&lt;/div&gt;</summary>
		<author><name>Angle3oil</name></author>	</entry>

	</feed>